JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

JNJ

168.27

-0.78%↓

NVS

117.59

+0.37%↑

ABT

126.59

+0.73%↑

MDT

92.9

+0.6%↑

ELV.US

289.29

+3.16%↑

Search

Thermo Fisher Scientific Inc

Fechado

SetorSaúde

478.65 0.72

Visão Geral

Variação de preço das ações

24h

Atual

Mín

476.33

Máximo

480.26

Indicadores-chave

By Trading Economics

Rendimento

-309M

1.5B

Vendas

-1B

10B

P/E

Médio do Setor

23.75

38.156

EPS

5.15

Rendimento de Dividendos

0.39

Margem de lucro

14.618

Funcionários

125,000

EBITDA

-1.3B

1.7B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+13.6% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.39%

2.50%

Próximos Ganhos

22 de out. de 2025

Próxima data de dividendos

15 de out. de 2025

Próxima data de ex-dividendo

15 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-50B

153B

Abertura anterior

477.93

Fecho anterior

478.65

Sentimento de Notícias

By Acuity

33%

67%

74 / 375 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Bearish Evidence

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de jul. de 2025, 10:33 UTC

Ganhos

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 de jun. de 2025, 21:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 de mai. de 2025, 14:02 UTC

Aquisições, Fusões, Aquisições de Empresas

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 de abr. de 2025, 10:33 UTC

Ganhos

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

25 de fev. de 2025, 14:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Net $1.62B >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q EPS $4.28 >TMO

23 de jul. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 2Q Rev $10.85B >TMO

14 de jul. de 2025, 16:12 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 de jul. de 2025, 15:06 UTC

Aquisições, Fusões, Aquisições de Empresas

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 de mai. de 2025, 13:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 de abr. de 2025, 10:01 UTC

Ganhos

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q EPS $3.98 >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Rev $10.36B >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Adj EPS $5.15 >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Net $1.51B >TMO

25 de fev. de 2025, 14:09 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 de fev. de 2025, 13:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Expects Deal to Be Neutral to 2025 EPS >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Deal Accelerates Business Transformation and Sharpens Focus on Strategic Areas for Growth

25 de fev. de 2025, 13:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Announces Sale of Its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

25 de fev. de 2025, 13:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher: Solventum Business Generated About $1 Billion Revenue in 2024 >TMO

25 de fev. de 2025, 13:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher to Buy Solventum Purification, Filtration Business for About $4.1 Billion Cash >TMO SOLV

25 de fev. de 2025, 13:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific To Acquire Solventum's Purification And Filtration Business >TMO

24 de fev. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific Nears Deal for Solventum's Purification and Filtration Business, Sources Say -- WSJ

Comparação entre Pares

Variação de preço

Thermo Fisher Scientific Inc Previsão

Preço-alvo

By TipRanks

13.6% parte superior

Previsão para 12 meses

Média 543.35 USD  13.6%

Máximo 590 USD

Mínimo 490 USD

Com base em 18 analistas de Wall Street que oferecem metas de preço de 12 meses para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

18 ratings

14

Comprar

4

Manter

0

Vender

Pontuação Técnica

By Trading Central

406.5 / 417.79Suporte e Resistência

Curto Prazo

Bearish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Strong Bearish Evidence

Sentimento

By Acuity

74 / 375 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar